Why intervene when the intestinal barrier is altered
Increased intestinal permeability is not an independent disease, but a biological condition in which the intestinal barrier loses part of its ability to select what enters the body.
When this balance is altered, inflammatory signals, oxidative stress, immune activation, and alterations in communication between the microbiota and the intestinal mucosa may increase.
The goal of an integrated approach is not to “seal the gut,” but to support the physiological mechanisms that regulate inflammation, mucosal integrity, and the dialogue between the microbiota and the immune system.
PRODUCT_ITEM
In this context, a support strategy can be included with:
1 Cistaloe capsule at lunch and 1 capsule at dinner
1 Lunae tablet at lunch and 1 tablet at dinner
The protocol should be considered nutritional support and does not replace medical evaluations in cases of persistent symptoms.
Lunae: support for the physiological control of intestinal inflammation
Lunae is formulated with a combination of bromelain, standardized Boswellia serrata extract, and tetrahydrocurcuminoids from turmeric.
The biological idea behind the formulation is to intervene at different stages of the inflammatory response.
Bromelain is an enzyme complex derived from pineapple studied for its role in modulating the inflammatory response and regulating immune activity.
Boswellia serrata contains boswellic acids that act on the inflammatory cascade through the modulation of 5-lipoxygenase and cellular mediators involved in cytokine production.
In the intestinal context, some experimental studies suggest that Boswellia derivatives may contribute to maintaining the integrity of the epithelial barrier and protecting tight junction proteins under conditions of inflammatory stress.
Tetrahydrocurcuminoids represent highly bioavailable metabolites of turmeric with antioxidant activity and the ability to modulate intracellular signals involved in the oxidative response.
The clinical rationale for taking 1 tablet at lunch and 1 at dinner is to distribute anti-inflammatory support throughout the day, accompanying the main digestive moments.
Cistaloe: support for mucosal balance and the microbiota
Cistaloe is included in the protocol with the goal of supporting the intestinal microenvironment and reducing the irritant load that can keep the inflammatory response active.
According to the characteristics of the product from the Moltitudo line, the formulation uses plant-based ingredients aimed at the functional support of the mucosa and the biological balance of the body.
In the context of intestinal permeability, the rationale for one capsule at lunch and one at dinner is to promote continuous exposure to active compounds during the daily digestive cycle.
Continuous support may be consistent with the physiological mechanisms of intestinal mucosal regeneration, which occurs with a high cellular turnover.
Why the combination may make biological sense
The combination of Cistaloe and Lunae is based on a concept of complementarity.
On one hand, Lunae works on the inflammatory context and oxidative stress.
On the other, Cistaloe is included to support the intestinal biological environment and promote conditions more favorable to maintaining barrier function.
This approach is consistent with current knowledge of the microbiota–mucosa–immune system axis, according to which the recovery of intestinal function often requires simultaneous interventions on inflammation, nutrition, and microbiota composition.
How to support the protocol
To obtain the maximum benefit, it is useful to combine:
a diet rich in plant fibers
adequate protein intake
limitation of ultra-processed foods
regular physical activity
adequate sleep
stress management
These elements directly influence the production of short-chain fatty acids, the integrity of tight junctions, and gut–brain communication.
Conclusions
The protocol with 1 Cistaloe capsule at lunch and dinner and 1 Lunae tablet at lunch and dinner stems from a rationale aimed at supporting the physiological inflammatory response and intestinal barrier function.
The goal is not the treatment of a single disease but the support of the mechanisms that maintain intestinal balance in the context of increased permeability and low-grade chronic inflammation.
PLEASE NOTE: The information in the product sheets on this site is for informational and educational purposes only and does not represent medical advice. The published content is not intended to replace the relationship with a doctor or any medical evaluations, diagnoses, or prescriptions. The information provided describes the ingredients and characteristics of food supplements, designed as support for the balance and well-being of the body within a healthy lifestyle. Food supplements are not medicines and must not be used to prevent, diagnose, treat, or alleviate diseases or pathological conditions.
Bibliography
Fasano A. Intestinal permeability and its regulation by zonulin. Clin Gastroenterol Hepatol. 2012.
Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009.
Camilleri M. Leaky gut: mechanisms, measurement and clinical implications. Gut. 2019.
Catanzaro R et al. Boswellia serrata preserves intestinal epithelial barrier from inflammatory damage. PLoS ONE. 2015.
Furusawa Y et al. Commensal microbe-derived butyrate induces regulatory T cells. Nature. 2013.
Kelly JR et al. Gut microbiome, intestinal permeability and stress disorders. Front Cell Neurosci. 2015.
